• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reply to Hiten D. Patel and Mohamad E. Allaf's letter to the editor re: Maxine Sun, Andreas Becker, Zhe Tian, et al. Management of localized kidney cancer: calculating cancer-specific mortality and competing risks of death for surgery and nonsurgical management. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.03.034.

作者信息

Sun Maxine, Karakiewicz Pierre I, Trinh Quoc-Dien

机构信息

Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada.

出版信息

Eur Urol. 2013 Nov;64(5):e107-8. doi: 10.1016/j.eururo.2013.07.025. Epub 2013 Jul 25.

DOI:10.1016/j.eururo.2013.07.025
PMID:23910940
Abstract
摘要

相似文献

1
Reply to Hiten D. Patel and Mohamad E. Allaf's letter to the editor re: Maxine Sun, Andreas Becker, Zhe Tian, et al. Management of localized kidney cancer: calculating cancer-specific mortality and competing risks of death for surgery and nonsurgical management. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.03.034.对希滕·D·帕特尔和穆罕默德·E·阿拉夫致编辑的信的回复，信的主题为：马克辛·孙、安德烈亚斯·贝克尔、田哲等人。局限性肾癌的管理：计算手术和非手术治疗的癌症特异性死亡率及死亡竞争风险。《欧洲泌尿外科杂志》。即将发表。http://dx.doi.org/10.1016/j.eururo.2013.03.034 。
Eur Urol. 2013 Nov;64(5):e107-8. doi: 10.1016/j.eururo.2013.07.025. Epub 2013 Jul 25.
2
Re: Maxine Sun, Andreas Becker, Zhe Tian, et al. Management of localized kidney cancer: calculating cancer-specific mortality and competing risks of death for surgery and nonsurgical management. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.03.034.回复：马克辛·孙、安德烈亚斯·贝克尔、田哲等。局限性肾癌的管理：计算手术和非手术治疗的癌症特异性死亡率及死亡的竞争风险。《欧洲泌尿外科杂志》。即将发表。http://dx.doi.org/10.1016/j.eururo.2013.03.034
Eur Urol. 2013 Nov;64(5):e105-6. doi: 10.1016/j.eururo.2013.07.023. Epub 2013 Jul 25.
3
Reply to Marc Bjurlin, Elena Elkin, and William Huang's Letter to the Editor re: Maxine Sun, Andreas Becker, Zhe Tian, et al. Management of localized kidney cancer: calculating cancer-specific mortality and competing risks of death for surgery and nonsurgical management. Eur Urol 2014;65:235-41.
Eur Urol. 2015 Apr;67(4):e72. doi: 10.1016/j.eururo.2014.07.023. Epub 2014 Aug 29.
4
Re: Maxine Sun, Andreas Becker, Zhe Tian, et al. Management of localized kidney cancer: calculating cancer-specific mortality and competing risks of death for surgery and nonsurgical management. Eur Urol 2014;65:235-41.回复：马克辛·孙、安德烈亚斯·贝克尔、田哲等人。局限性肾癌的管理：计算手术和非手术治疗的癌症特异性死亡率及死亡的竞争风险。《欧洲泌尿外科杂志》2014年；65卷：235 - 41页
Eur Urol. 2015 Apr;67(4):e71. doi: 10.1016/j.eururo.2014.07.024. Epub 2014 Aug 29.
5
Re: management of localized kidney cancer: calculating cancer-specific mortality and competing risks of death for surgery and nonsurgical management.关于：局限性肾癌的管理：计算手术和非手术治疗的癌症特异性死亡率及死亡竞争风险。
J Urol. 2014 May;191(5):1262-3. doi: 10.1016/j.juro.2014.02.018. Epub 2014 Feb 20.
6
Reply to E. David Crawford and Bo-Eric Persson's letter to the editor re: Giorgio Gandaglia, Maxine Sun, Jim C. Hu, et al. Gonadotropin-releasing hormone agonists and acute kidney injury in patients with prostate cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2014.01.026.对E. 大卫·克劳福德和博 - 埃里克·佩尔松致编辑的信的回复，信的内容涉及：乔治·甘达利亚、马克辛·孙、吉姆·C·胡等人的《促性腺激素释放激素激动剂与前列腺癌患者的急性肾损伤》。《欧洲泌尿外科杂志》。即将发表。http://dx.doi.org/10.1016/j.eururo.2014.01.026
Eur Urol. 2014 Aug;66(2):e36-7. doi: 10.1016/j.eururo.2014.03.043. Epub 2014 Apr 13.
7
Re: Giorgio Gandaglia, Maxine Sun, Jim C. Hu, et al. Gonadotropin-releasing hormone agonists and acute kidney injury in patients with prostate cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2014.01.026.回复：乔治·甘达利亚、马克辛·孙、吉姆·C·胡等人。促性腺激素释放激素激动剂与前列腺癌患者的急性肾损伤。《欧洲泌尿外科杂志》。即将发表。http://dx.doi.org/10.1016/j.eururo.2014.01.026 。
Eur Urol. 2014 Aug;66(2):e34-5. doi: 10.1016/j.eururo.2014.03.044. Epub 2014 Apr 13.
8
Reply to Nirmish Singla and Vitaly Margulis's Letter to the Editor re: Geraldine Pignot, Antoine Thiery-Vuillemin, Jochen Walz, et al. Nephrectomy After Complete Response to Immune Checkpoint Inhibitors for Metastatic Renal Cell Carcinoma: A New Surgical Challenge? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.12.018. The Next Surgical Frontier in Kidney Cancer: Nephrectomy After Immune Checkpoint Inhibition: Nephrectomy After Immunotherapy: The Duration of Treatment Exposure is Probably Decisive.回复尼米什·辛格拉和维塔利·马尔古利斯致编辑的信，信中涉及：杰拉尔丁·皮尼奥、安托万·蒂埃里 - 维勒明、约亨·瓦尔兹等人。转移性肾细胞癌对免疫检查点抑制剂完全缓解后的肾切除术：一项新的手术挑战？《欧洲泌尿外科杂志》。即将发表。https://doi.org/10.1016/j.eururo.2019.12.018。肾癌的下一个手术前沿：免疫检查点抑制后的肾切除术：免疫治疗后的肾切除术：治疗暴露时间可能起决定性作用。
Eur Urol. 2020 Aug;78(2):e81-e82. doi: 10.1016/j.eururo.2020.04.052. Epub 2020 May 7.
9
Management of localized kidney cancer: calculating cancer-specific mortality and competing risks of death for surgery and nonsurgical management.局限性肾癌的治疗：计算手术和非手术治疗的癌症特异性死亡率和死亡竞争风险。
Eur Urol. 2014 Jan;65(1):235-41. doi: 10.1016/j.eururo.2013.03.034. Epub 2013 Mar 27.
10
Re: Bimal Bhindi, Jeffrey Graham, J. Connor Wells, et al. Deferred Cytoreductive Nephrectomy in Patients with Newly Diagnosed Metastatic Renal Cell Carcinoma. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.04.038: Cytoreductive Nephrectomy: To Whom and When?回复：比马尔·宾迪、杰弗里·格雷厄姆、J·康纳·韦尔斯等人。初诊转移性肾细胞癌患者的延期减瘤性肾切除术。《欧洲泌尿外科杂志》。即将发表。https://doi.org/10.1016/j.eururo.2020.04.038：减瘤性肾切除术：适用于谁以及何时进行？
Eur Urol Oncol. 2020 Aug;3(4):559-560. doi: 10.1016/j.euo.2020.05.011. Epub 2020 Jun 15.